REALIXIA
Why North America Leads Innovation in Yersinia Diagnostic Testing Solutions
Across North America, the diagnosis of Yersinia infections is supported by well-established healthcare infrastructure, advanced laboratory capabilities, and increasing focus on foodborne and zoonotic disease surveillance. Growing awareness of gastrointestinal infections and the importance of early pathogen identification are encouraging the use of molecular and other advanced diagnostic...
1.2K Vizualizări